2022 New Style Diosmin - Mitomycin C 50-07-7 Antibiotic Antineoplastic – Neore
2022 New Style Diosmin - Mitomycin C 50-07-7 Antibiotic Antineoplastic – Neore Detail:
Payment: T/T, L/C
Product Origin: China
Shipping Port: Beijing/Shanghai/Hangzhou
Production capacity: 5kg/month
Order(MOQ): 10g
Lead Time: 3 Working Days
Storage condition: Stored in cool, dry place, room temperature.
Package material: vial
Package size: 10g/drum
Safety information: UN 2811 6.1/ PG 1
Description
Mitomycin C is a mitomycin that is used as a chemotherapeutic agent by virtue of its antitumour activity.
It is given intravenously to treat upper gastro-intestinal cancers (e.g. esophageal carcinoma), anal cancers, and breast cancers, as well as by bladder instillation for superficial bladder tumours.
Mitomycin C is used in cancers, particularly bladder cancers and intraperitoneal tumours.
Mitomycin C is used in eye surgery where mitomycin C 0.02% is applied topically to prevent scarring during glaucoma filtering surgery and to prevent haze after PRK or LASIK; mitomycin C has also been shown to reduce fibrosis in strabismus surgery.
Mitomycin C is used in esophageal and tracheal stenosis where application of mitomycin C onto the mucosa immediately following dilatation will decrease re-stenosis by decreasing the production of fibroblasts and scar tissue.
Specification (USP/EP)
Item |
Specification |
Appearance |
Blue-violet, crystalline powder |
Identification |
IR: The IR spectrum of the sample corresponds to the spectrum of reference standard |
HPLC: The retention time of the major peak of the sample solution corresponds to that of the standard solution, as obtained in the Assay | |
pH |
6.0~7.5 |
Water |
Not more than 2.5% |
Crystallinity |
Should conforms |
Related Substances | |
Albomitomycin C
(EP Impurity D) |
Not more than 0.5% |
Mitomycin B
(EP Impurity C) |
Not more than 0.5% |
Cinnamamide
(EP Impurity A) |
Not more than 0.5% |
Mitomycin A
(EP Impurity B) |
Not more than 0.5% |
Any Individual Unspecified Impurity |
Not more than 0.5% |
Total Impurities |
Not more than 2.0% |
Residual Solvents | |
Methanol |
Not more than 3000 ppm |
Methylene Chloride |
Not more than 600 ppm |
Ethyl Acetate |
Not more than 5000 ppm |
Bacterial Endotoxins |
Not more than 10 EU/mg |
Assay |
Not less than 970 mg/g of Mitomycin |
Product detail pictures:
Related Product Guide:
"Sincerity, Innovation, Rigorousness, and Efficiency" would be the persistent conception of our enterprise with the long-term to build with each other with consumers for mutual reciprocity and mutual advantage for 2022 New Style Diosmin - Mitomycin C 50-07-7 Antibiotic Antineoplastic – Neore , The product will supply to all over the world, such as: Zambia, Ecuador, Washington, We've a good reputation for stable quality solutions, well received by customers at home and abroad. Our company would be guided by the idea of "Standing in Domestic Markets, Walking into International Markets". We sincerely hope that we could do business with customers both at home and abroad. We expect sincere cooperation and common development!
By Judy from Netherlands - 2017.11.20 15:58
Reasonable price, good attitude of consultation, finally we achieve a win-win situation,a happy cooperation!
By Jean from San Francisco - 2017.10.13 10:47